Home
>
National Drug Code (NDC)
>
REBETOL
REBETOL - 0085-1385-07 - (ribavirin)
Drug Information of REBETOL
| Product NDC: | 0085-1385 |
| Proprietary Name: | REBETOL |
| Non Proprietary Name: | ribavirin |
| Active Ingredient(s): | 200 mg/1 & nbsp; ribavirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REBETOL
| Product NDC: | 0085-1385 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020903 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980603 |
Package Information of REBETOL
| Package NDC: | 0085-1385-07 |
| Package Description: | 70 CAPSULE in 1 BOTTLE (0085-1385-07) |
NDC Information of REBETOL
| NDC Code | 0085-1385-07 |
| Proprietary Name | REBETOL |
| Package Description | 70 CAPSULE in 1 BOTTLE (0085-1385-07) |
| Product NDC | 0085-1385 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ribavirin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19980603 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | RIBAVIRIN |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
